(4.3) (79.6) Total comprehensive income for the year 132.6 209.2 228.1 246.5 18.4 8.1 816.4 552.0 264.4 47.9 2019 2018Change QoQ Change YoYConsolidated financial statements Q1-2019 Q2-2019 Q3-2019 Q4
Power Generation Others Total Change Increase (Decrease) Quarter 2 Quarter 2 Quarter 2 Quarter 2 2020 2019 2020 2019 2020 2019 Amount % Total Revenues 10,446 11,017 118 158 10,564 11,175 (611) (5%) Total
relevant agreements are as follows: (1) The shareholders’ meeting of the Company shall have approved the entering into the Transaction; and (2) No change has occurred, which causes a material adverse effect
follows: (1) The shareholders’ meeting of the Company shall have approved the entering into the Transaction; and (2) No change has occurred, which causes a material adverse effect on assets, liabilities
SUMMARY EXECUTIVE SUMMARY 2 2017 2018 % change Q3’2018 Q4’2018 % change million Baht million Baht y-on-y million Baht million Baht q-on-q Sales and service income 31,482 36,585 16.2% 9,691 9,933 2.5% EBITDA
EXECUTIVE SUMMARY 2 Q1’2017 Q1’2018 % change Q4’2017 Q1’2018 % change million Baht million Baht y-on-y million Baht million Baht q-on-q Sales and service income 7,651 8,156 6.6% 7,762 8,156 5.1% EBITDA 2,133
63.1% of NNP. ABBREVIATION & OUR PROJECTSFINANCIAL PERFORMANCE FINANCIAL POSITION PROGRESS OF PROJECTS UNDER CONSTRUCTION EXECUTIVE SUMMARY EXECUTIVE SUMMARY 2 6M’2017 6M’2018 % change Q1’2018 Q2’2018
EXECUTIVE SUMMARY EXECUTIVE SUMMARY 2 9M’18 9M’19 change Q3’18 Q2’19 Q3’19 change change Btmn Btmn y-on-y Btmn Btmn Btmn y-on-y q-on-q Sales and service income 26,652 32,874 23.3% 9,691 10,866 11,751 21.3
EXECUTIVE SUMMARY EXECUTIVE SUMMARY 2 6M’18 6M’19 change Q2’18 Q1’19 Q2’19 change change Btmn Btmn y-on-y Btmn Btmn Btmn y-on-y q-on-q Sales and service income 16,961 21,123 24.5% 8,805 10,257 10,866 23.4
granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change